MedTrace Logo

Quality of Life in Patients With Rectal Cancer Receiving Total Mesorectal Excision With or Without Stoma

NCT03487484 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 5

Last updated 2020-04-10

No results posted yet for this study

Summary

The goal is to evaluate whether the renunciation of a diverting stoma in patients with adjuvant chemotherapy after low anterior resection with total mesorectal excision (TME) and neoadjuvant chemoradiotherapy leads to a better quality of life without increasing morbidity and mortality in patients with rectal cancer.

Conditions

Interventions

BEHAVIORAL

Quality of Life Questionnaire for gastrointestinal tract

To assess quality of life, the GIQLI questionnaire (Gastrointestinal Quality of Life Index) will be applied

BEHAVIORAL

Quality of Life Questionnaire

To assess quality of life, the SF-36 questionnaire will be applied

BEHAVIORAL

Faecal Incontinence Score

To assess faecal incontinence, the Vaizey Wexner questionnaire will be applied

Sponsors & Collaborators

  • University Hospital, Basel, Switzerland

    lead OTHER

Principal Investigators

  • Susanne Drews, MD · Claraspital Basel

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-22
Primary Completion
2020-03-22
Completion
2020-03-22

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03487484 on ClinicalTrials.gov